Gpi Spa · MIL:GPI
Gpi Spa — Merger or Acquisition (July 2023)
18 slides from Gpi Spa's merger presentation, Jul 4, 2023
Slide 1: Innovation for sustainable Healthcare – Acquisition of Evolucare Group
Innovation for sustainable Healthcare Acquisition of Evolucare Group - 4th July 2023 EN 1
Slide 2: Vision, Mission, Values
VISION 35 years of experience, History of to be at the forefront of the technological Growth management team with a track record of internal growth and and sustainable transformation of M&As preventive and care processes for healthcare, promoting the well-being of International solutions used by 3,0
Slide 3: M&A Guidelines
M&A Guidelines SOFTWARE HOUSE INTERNATIONAL EBITDA margin ~37% INTEGRATION with GPI’s French subsidiaries OPTIMIZATION creation of a HUB OF TECHNOLOGICAL EXCELLENCE To become one of the major players Potential SYNERGIES at the European level in the software for healthcare 33
Slide 4: Evolucare: a reference player in the French digital health sector
Evolucare: a reference player in the French digital health sector Company description Key financials • Established in 1988 by the Le Guilcher family, Evolucare is a leading French software provider specialized in the healthcare sector 42.9 • Evolucare focuses on B2B solutions with a comprehensive an
Slide 5: Comprehensive products offering for the clinical and medico-social sectors
Comprehensive products offering for the clinical and medico-social sectors BU/Segment Main products Description Hospital Information • Launched in 1996, multi-activity EPR used by all types of hospitals and nursing homes System / Electronic Patient Record • New generation web-based solution designed
Slide 6: International footprint & strong export potential
International footprint & strong export potential FY22 revenues by geography Historical presence in France and recent international expansion in the DACH region International presence in key selected countries (North Africa and Hong Kong and in US and Latin America through partnerships) RoW Eu ~0.4
Slide 7: Strategic rationale of the acquisition of Evolucare
Strategic rationale of the acquisition of Evolucare 1 Expansion of the Software Strategic Business Area: SBA revenues + ~26% and EBITDA + ~35% Strengthening of GPI’s proprietary software offering: combined commercial offering in Critical Care, 2 Medical-Social and Ophthalmology & consolidation in Ho
Slide 8: Higher contribution from the Software Strategic Business Area…
Higher contribution from the Software Strategic Business Area… + 2022 revenues pro-forma +26% 220 43 429 Revenues 167 209 (Eu mn) ASA Software GPI Evoluacre Asa software GPI+Evolucare Altre ASA GPI SBA software SBA software Other SBA 2022 pro forma 2022 EBITDA pro-forma +35% ~18% 17 16 77 EBITDA 61
Slide 9: …leading to an increased EBITDA margin and international footprint
…leading to an increased EBITDA margin and international footprint Breakdown per Strategic Business Area Revenues per geography1 EBITDA margin Revenues EBITDA Other Other SBA Abroad SBA 13% 17% 14% SBA 43% 10% € 386mn Care € 62mn € 386mn ~16.0% SBA SBA 44% Software 73% SBA 86% Care Software Italy Ot
Slide 10: Expected synergies from the complementarity of GPI and Evolucare solutions
Expected synergies from the complementarity of GPI and Evolucare solutions ▪ Sales Synergies: Operational ▪ Potential cross-selling to existing customers in their respective areas (Italy, France, DACH) in the areas of: ➢ Blood, Automation, LIS (GPI solutions) ➢ Critical Care, and Ophthalmology (Evol
Slide 11: a History of Steady Growth
a History of Significant contribution from value-accretive M&A Steady Revenue ‘22PF EBITDA ‘22PF Growth € ~429 M € ~77 M % on adj. Revenue 18.1% 16.7% 16.4% 16.0% ~429 M&A deals 15.2% 360.2 14.8% 15.1% ~77 326.9 271.0 54.2 49.8 ca. 7k € 200 M 40.2 Employees in the last 6 years 3,000 + 2020A 2021A 20
Slide 12: Strategic Pillars of the Business Plan 2022 – 2024
Strategic Pillars of the Business Plan 2022 – 2024 Values, Mission and Vision 20-30% revenue abroad Primary role in Italy and France Innovative solutions 1. 2. 3. 4. Global Protagonist Interconnected Innovative and Secure Targets €M 2022 pro forma 2024 Disclosed Targets Inorganic Revenue Organic Rev
Slide 13: Transaction structure and indicative timeline
Transaction structure and indicative timeline At Closing 12 months after Closing 2028 Managers Managers 3.4% 6.2% Equity value fully diluted Put & Call options on minority stakes held Transaction € 116 mn by Evolucare’s top 93.8% managers structure 96.6% EV/EBITDA 2022 Evolucare’s managers to GPI Fr
Slide 14: Q&A
Q&A 14
Slide 15: Q&A - Acquisition of Evolucare
Q&A - Acquisition of Evolucare STRATEGIC RATIONALE DEAL CONSIDERATION • ~35 years of presence in the French • Purchase ~96.6% of Evolucare at • Expansion of the Software Strategic digital health sector closing for Euro ~108.8mn Business Area (+26% of 2022PF • Comprehensive suite of software for • EV
Slide 16: IR Contacts
IR Contacts Via Ragazzi del '99, 13 - 38123 Trento T +39 0461 381515 investor.relations@gpi.it Fabrizio Redavid Lorenzo Giollo C. +39 335 1035499 C. +39 340 8223333 fabrizio.redavid@gpi.it lorenzo.giollo@gpi.it 16 - Maggio 2018
Slide 17: Disclaimer
Disclaimer The material in this presentation was prepared by GPI S.p.A. ("GPI” or the “Company”) without (financial promotion), the Order of Financial Services and markets and/or companies with high any form of independent verification; it is general, basic information about the current business sha
Slide 18: GPI SpA
GPI SpA |-38123 Trento (TN) Via Ragazzi del ‘99, n. 13 T +39 0461 381 515 info@gpi.it www. gpigroup.com Cf) ® (a) 18